Mednet Logo

What head and neck subsites would you treat for a SCC of multiple ipsilateral neck nodes (clinical ECE, no contralateral nodes) with unknown primary origin site despite full workup?

Would you spare contralateral neck? Does your recommendation change depending on p16 status?
6 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

Oropharynx, bilateral neck, ipsilateral RP nodes, and nasopharynx. You could omit the NPX but you’re up there anyway to treat the RPs.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Levine Cancer Institute
Answered on

With such bulk in the neck, the contralateral neck and ipsilateral RP nodes should be treated. Regarding mucosal coverage, recent ASCO guidelines suggest the ipsilateral oropharynx can be treated alone regardless of p16. However, as @Dr. First Last said, with the RPs being so close, coverage of the ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of California San Diego
Answered on

For me, the answer depends on P16 status and nodal location(s). If P16+ and level II-V, I would presume it is a pharyngeal primary and treat the pharyngeal axis including the nasopharynx, oropharynx, and ipsilateral pharyngeal wall. I typically include the nasopharynx because a reasonable number of ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Emory University School of Medicine
Answered on

The ASCO Consensus Guidelines referenced by @Dr. First Last are a great resource. If the primary site remains occult after a comprehensive work-up, clinicopathologic features can guide mucosal and contralateral neck coverage. If pathology (ISH for EBV or HPV) or history (prior H&N NMSCs) suggests a ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Michigan
Answered on

I agree with my colleagues' posts and would offer a few general comments on the subject, as well as some specific to the case presented.

As noted by others, several factors must be taken into account and there is no "one-size-fits-all" recommendation for H&N SCCUP, though the ASCO guidelines refere...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · HCA South Atlantic
Answered on

Agree with Dr. Mendenhall with regards to managing p16 negative disease (stage IVB). I would give chemo+RT (Ipsilateral oropharynx, possibly ipsilateral hypopharynx, bilateral necks, bilateral RP nodes). Management of p16+ (stage I) would, however, have to be more nuanced based on age, PS, smoking h...

Join for free or sign in to see the full answer